CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes

Active, not recruitingOBSERVATIONAL

Enrollment

440

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions

Type 2 Diabetes

Trial Locations (1)

HUB-Hôpital ERASME, Brussels

All Listed Sponsors

lead

Erasme University Hospital

OTHER

NCT07064499 - CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes | Biotech Hunter | Biotech Hunter